Mingxia Jiang

2.0k total citations · 1 hit paper
49 papers, 1.5k citations indexed

About

Mingxia Jiang is a scholar working on Biomedical Engineering, Molecular Biology and Oncology. According to data from OpenAlex, Mingxia Jiang has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 14 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Mingxia Jiang's work include Nanoplatforms for cancer theranostics (11 papers), HER2/EGFR in Cancer Research (6 papers) and Inflammasome and immune disorders (6 papers). Mingxia Jiang is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), HER2/EGFR in Cancer Research (6 papers) and Inflammasome and immune disorders (6 papers). Mingxia Jiang collaborates with scholars based in China, United States and Bangladesh. Mingxia Jiang's co-authors include Ling Qi, Yanjing Li, Lisha Li, Yiming Wu, Dongfeng Song, Weifen Zhang, Xiuwen Guan, Junqing Gan, Yuxian Bai and Jinlong Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Journal of Colloid and Interface Science.

In The Last Decade

Mingxia Jiang

46 papers receiving 1.4k citations

Hit Papers

The caspase-3/GSDME signal pathway as a switch between ap... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxia Jiang China 17 881 380 312 271 217 49 1.5k
Shunying Li China 13 1.4k 1.6× 477 1.3× 151 0.5× 345 1.3× 330 1.5× 32 1.9k
Jiadi Lv China 22 1.2k 1.3× 797 2.1× 325 1.0× 176 0.6× 491 2.3× 37 2.3k
Yanjing Li China 11 817 0.9× 247 0.7× 100 0.3× 244 0.9× 127 0.6× 13 1.1k
Prasanthi Karna United States 16 629 0.7× 138 0.4× 132 0.4× 75 0.3× 214 1.0× 21 1.2k
Haiping Jiang China 18 562 0.6× 191 0.5× 176 0.6× 197 0.7× 385 1.8× 45 1.2k
Xi Wu China 16 1.4k 1.6× 303 0.8× 165 0.5× 305 1.1× 227 1.0× 48 1.8k
Cailian Wang China 19 390 0.4× 85 0.2× 442 1.4× 198 0.7× 165 0.8× 53 1.4k
Xian‐Ming Chu China 22 892 1.0× 204 0.5× 88 0.3× 140 0.5× 144 0.7× 61 1.7k
Pei Zhang China 23 1.2k 1.3× 368 1.0× 85 0.3× 375 1.4× 356 1.6× 109 2.1k

Countries citing papers authored by Mingxia Jiang

Since Specialization
Citations

This map shows the geographic impact of Mingxia Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxia Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxia Jiang more than expected).

Fields of papers citing papers by Mingxia Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxia Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxia Jiang. The network helps show where Mingxia Jiang may publish in the future.

Co-authorship network of co-authors of Mingxia Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxia Jiang. A scholar is included among the top collaborators of Mingxia Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxia Jiang. Mingxia Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Mingxia, et al.. (2025). Changes in bile acid profiles and short-term weight loss in response to a low-calorie diet: a pilot study. Frontiers in Nutrition. 12. 1598933–1598933.
2.
Jiang, Mingxia, et al.. (2024). Microfluidic colorimetric biosensor for rapid and sensitive detection of Shewanella oneidensis MR‑1. Sensors and Actuators B Chemical. 424. 136872–136872. 2 indexed citations
3.
Jiang, Mingxia, Huapan Fang, & Huayu Tian. (2024). Metabolism of cancer cells and immune cells in the initiation, progression, and metastasis of cancer. Theranostics. 15(1). 155–188. 16 indexed citations
5.
Jiang, Mingxia, Mengqi Zhang, Yiqun Li, et al.. (2024). Pyrotinib combined with metronomic etoposide in heavily pretreated HER2-positive metastatic breast cancer: a single-arm, phase II study. BMC Cancer. 24(1). 1290–1290. 1 indexed citations
6.
Jiang, Mingxia, et al.. (2024). Recent advances in poly(amino acids), polypeptides, and their derivatives in drug delivery. Nanoscale. 17(7). 3549–3584. 11 indexed citations
7.
Li, Qiao, Mingxia Jiang, & Binghe Xu. (2023). A new perspective in the research of antibody drug conjugate. 1(2). 100018–100018. 3 indexed citations
8.
Jiang, Mingxia, Hui Zeng, Jiaxin Wu, et al.. (2023). Autogenous iron-based peroxidase-like nanozyme from paper mill sludge for ascorbic acid detection. Materials Today Communications. 36. 106775–106775. 7 indexed citations
10.
Guo, Linghong, et al.. (2023). New era of medical education: asynchronous and synchronous online teaching during and after COVID-19. AJP Advances in Physiology Education. 47(2). 272–281. 8 indexed citations
11.
Qi, Ling, et al.. (2023). Caspase‐6 is a key regulator of cross‐talk signal way in PANoptosis in cancer. Immunology. 169(3). 245–259. 23 indexed citations
12.
Zeng, Jun, Shuo Sun, Mingxia Jiang, et al.. (2022). Leveraging Nanodrug Delivery System for Simultaneously Targeting Tumor Cells and M2 Tumor-Associated Macrophages for Efficient Colon Cancer Therapy. ACS Applied Materials & Interfaces. 14(45). 50475–50484. 11 indexed citations
13.
Jiang, Mingxia, Wenjing Yu, Zhiwei Xu, et al.. (2021). Sequentially pH-Responsive Drug-Delivery Nanosystem for Tumor Immunogenic Cell Death and Cooperating with Immune Checkpoint Blockade for Efficient Cancer Chemoimmunotherapy. ACS Applied Materials & Interfaces. 13(37). 43963–43974. 23 indexed citations
14.
Chen, Wenqiang, Mingxia Jiang, Wenjing Yu, et al.. (2021). CpG-Based Nanovaccines for Cancer Immunotherapy. International Journal of Nanomedicine. Volume 16. 5281–5299. 62 indexed citations
15.
Jiang, Mingxia, Liping Zhao, Xiao-Ming Cui, et al.. (2021). Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy. Journal of Advanced Research. 35. 49–60. 26 indexed citations
16.
Gan, Junqing, Shumin Li, Yu Meng, et al.. (2020). The influence of photodynamic therapy on the Warburg effect in esophageal cancer cells. Lasers in Medical Science. 35(8). 1741–1750. 13 indexed citations
18.
Jiang, Mingxia, et al.. (2017). ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β1 pathway. Lipids in Health and Disease. 16(1). 216–216. 20 indexed citations
19.
Jiang, Mingxia, et al.. (2016). Analysis of Active Components and Proteomics of Chinese Wild Rice ( Zizania latifolia (Griseb) Turcz ) and Indica Rice ( Nagina22 ). Journal of Medicinal Food. 19(8). 798–804. 16 indexed citations
20.
Wang, Zhaofen, et al.. (2015). [Genotyping of Mycobacterium tuberculosis isolates circulating in Qinghai province by spoligotyping].. PubMed. 49(6). 565–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026